MAP BioPharma response to Lords Science and Technology inquiry into the future of UK Life Sciences

MAP BioPharma has submitted a written response to The House of Lords Science and Technology Select Committee inquiry into Life Sciences and the Industrial Strategy. The inquiry, which is being conducted under the Chairmanship of Lord Patel, aims to contribute to the discussion around the Life Sciences strategy published by Sir John Bell and the role of the Government and business in its development and implementation.

To read MAP BioPharma’s response, please log in.

Tagged with

Published on 19. September 2017 in News UK